In the tough market conditions last year, investors and big pharma companies were more likely to place their bets on later, ...

A critical malware threat has been discovered targeting Gmail and Outlook users, with malicious code hidden in email images.

Chardan Capital analyst Daniil Gataulin maintained a Hold rating on Outlook Therapeutics (OTLK – Research Report) today and set a price target ...

The prestigious 10th Edition of the Outlook Business Spotlight Awards - Achievers Awards 2024 concluded successfully on 21st ...

Learn how to add and remove Outlook add-ins with ease. Boost your email mastery with our guide on managing add-ins on all ...

The 69th Greater Horn of Africa Climate Outlook Forum (GHACOF 69), under the theme: "Climate Services for Closing the Early ...

Global growth is projected at 3.3 percent both in 2025 and 2026, broadly unchanged from the October 2024 World Economic ...

It shouldn’t come as a shock given what we’ve seen before — but it likely will. A genuine hacking disaster is heading for ...

Outlook Therapeutics Inc (OTLK) stock saw a modest uptick, ending the day at $2.23 which represents a slight increase of $0.04 or 1.83% from the prior close of $2.19. The stock opened at $2.19 and ...

The United States Department of Agriculture announces the addition of two prominent speakers to the agenda for the 101st Agricultural Outlook Forum, “Meeting Tomorrow’s Challenges, Today,” scheduled ...

Fintel reports that on January 17, 2025, Wedbush downgraded their outlook for Keros Therapeutics (NasdaqGM:KROS) from ...

Piper Sandler adjusted its outlook on Keros Therapeutics (NASDAQ:KROS), significantly reducing the price target from $40.00 ...